Market Overview

Sage Therapeutics (NASDAQ: SAGE)

91.38 -5.38 (-5.56%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/04/21RBC CapitalDowngradesSector Perform86.0
1/04/21GuggenheimUpgradesBuy
12/04/20MizuhoUpgradesBuy81.0
12/01/20Morgan StanleyMaintainsEqual-Weight83.0
12/01/20HC Wainwright & Co.MaintainsNeutral74.0
12/01/20Raymond JamesDowngradesMarket Perform
11/16/20B of A SecuritiesMaintainsBuy95.0
11/16/20Morgan StanleyDowngradesEqual-Weight85.0
11/06/20Canaccord GenuityMaintainsBuy135.0
11/06/20BMO CapitalMaintainsOutperform89.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter